ACoP 2024
Nov 10 - 13, 2024 | Phoenix, AZ
The agents listed below are currently under investigation. Their safety and efficacy have not been established.
Poster
Population Pharmacokinetic (PopPK) Model to Characterize Pharmacokinetics (PK) of Vepdegestrant, a Proteolysis Targeting Chimera (PROTAC) Estrogen Receptor (ER) Degrader, in Healthy Adult ParticipantsSK Drescher et al.